PELABRESIB: 37 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
37
Total FAERS Reports
4 (10.8%)
Deaths Reported
24
Hospitalizations
37
As Primary/Secondary Suspect
2
Life-Threatening
1
Disabilities
Active Ingredient: PELABRESIB MONOHYDRATE ·
First Report: 20220201 · Latest Report: 20241014
What Are the Most Common PELABRESIB Side Effects?
#1 Most Reported
Anaemia
8 reports (21.6%)
#2 Most Reported
Pneumonia
6 reports (16.2%)
#3 Most Reported
Syncope
5 reports (13.5%)
All PELABRESIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 8 | 21.6% | 1 | 8 |
| Pneumonia | 6 | 16.2% | 2 | 6 |
| Syncope | 5 | 13.5% | 0 | 5 |
Who Reports PELABRESIB Side Effects? Age & Gender Data
Average age: 75.2 years. Most reports from: US. View detailed demographics →
Is PELABRESIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2022 | 8 | 1 | 7 |
| 2023 | 9 | 0 | 4 |
| 2024 | 1 | 0 | 1 |
What Is PELABRESIB Used For?
| Indication | Reports |
|---|---|
| Myelofibrosis | 37 |
Official FDA Label for PELABRESIB
Official prescribing information from the FDA-approved drug label.